+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Systemic Aspergillosis and Systemic Candidiasis Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type, and Geography

  • ID: 5295167
  • Report
  • January 2021
  • Region: Global
  • 160 pages
  • The Insight Partners
UP TO OFF
until Jun 30th 2021

FEATURED COMPANIES

  • Abbott
  • Astellas Pharma Inc
  • Bayer Ag
  • Cipla
  • Glaxosmithkline Plc
  • Merck And Co. Inc
  • MORE
Systemic Oral Azoles Segment to Grow at Fast Pace During 2020-2027

According to the latest study on “Systemic Aspergillosis and Systemic Candidiasis Market Forecast to 2027 - COVID-19 Impact and Global Analysis - by Type and Application,” the market is expected to reach US$ 8,247.5 million by 2027 from US$ 6,056.3 million in 2019; it is estimated to grow at a CAGR of 4.0% from 2020 to 2027. The report provides trends prevailing in the global systemic aspergillosis and systemic candidiasis market, and the drivers and hindrances pertaining to the market growth.

Based on type, the systemic aspergillosis and systemic candidiasis market is segmented into voriconazole, liposomal amphotericin b, systemic oral azoles, topical antifungal agents, and others. In 2019, the systemic oral azoles segment held the largest share of the market. The same segment is expected to grow at the fastest rate during the coming years owing to rising number of invasive fungal infections. Oral azole drugs, such as fluconazole, ketoconazole, and itraconazole, have a major advantages in systemic antifungal therapy. Among all three, fluconazole has the most attractive pharmacologic (pharmacokinetics and pharmacodynamic) profile, including the capacity to produce high concentrations of active drug in cerebrospinal fluid and urine.

Rise in prevalence of fungal diseases and increase in incidence of hospital-acquired fungal infection are the key factors driving the systemic aspergillosis and systemic candidiasis market. Moreover increase in R&D activities and new drug pipeline are likely to have a positive impact on the market in the coming years. However, undiagnosed cases of systemic aspergillosis and systemic candidiasis are restricting the market growth.

Novartis Ag; Sanofi-Aventis; Pfizer, Inc.; Merck and Co., Inc.; Enzon Pharmaceuticals, Inc.; Bayer Ag; Astellas Pharma, Inc.; GlaxoSmithKline Plc; Abbott; and Cipla are among the leading companies operating in the systemic aspergillosis and systemic candidiasis market.

The report segments the global systemic aspergillosis and systemic candidiasis market as follows:

By Type
  • Systemic Oral Azoles
  • Voriconazole
  • Liposomal Amphotericin B
  • Topical Antifungal Agents
  • Others
By Application
  • Allergic Bronchopulmonary Aspergillosis (ABPA)
  • Chronic Pulmonary Aspergillosis (CPA)
  • Gastrointestinal Candidiasis
  • Genitourinary Tract Candidiasis
  • Other
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • South and Central America (SCAM)
  • Brazil
  • Argentina
Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Systemic Aspergillosis and Systemic Candidasis Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global percutaneous mechanical circulatory support devices market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Astellas Pharma Inc
  • Bayer Ag
  • Cipla
  • Glaxosmithkline Plc
  • Merck And Co. Inc
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Systemic Aspergillosis and Systemic Candidasis Market - By Type
1.3.2 Global Systemic Aspergillosis and Systemic Candidasis Market - By Application
1.3.3 Global Systemic Aspergillosis and Systemic Candidasis Market - By Geography

2. Systemic Aspergillosis And Systemic Candidasis Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Systemic Aspergillosis and Systemic Candidasis Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions
4.4 Clinical Trials Phases of Products Offered by Companies
4.5 Candida Specific Products

5. Systemic Aspergillosis and Systemic Candidasis Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Fungal Diseases
5.1.2 Rising Hospital Acquired Fungal Infection
5.2 Market Restraints
5.2.1 Increasing Resistance to Antifungal Drugs
5.2.2 Side Effects of Antifungal Drugs
5.3 Market Opportunities
5.3.1 Increase in R&D Activities and Pipeline of New Drug
5.4 Future Trends
5.4.1 Consolidation of Market
5.5 Impact Analysis

6. Systemic Aspergillosis And Systemic Candidasis Market - Global Analysis
6.1 Global Systemic Aspergillosis And Systemic Candidasis Market Revenue Forecast And Analysis
6.2 Global Systemic Aspergillosis And Systemic Candidasis Market, By Geography - Forecast And Analysis
6.3 Market Positioning

7. Systemic Aspergillosis and Systemic Candidasis Market Analysis- by Type
7.1 Overview
7.2 Global Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)
7.3 Voriconazole
7.3.1 Overview
7.3.2 Global Voriconazole Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Liposomal Amphotericin B
7.4.1 Overview
7.4.2 Global Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Systemic Oral Azoles
7.5.1 Overview
7.5.2 Global Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Topical Antifungal Agents
7.6.1 Overview
7.6.2 Global Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Others
7.7.1 Overview
7.7.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. Systemic Aspergillosis and Systemic Candidasis Market Analysis- by Application
8.1 Overview
8.2 Global Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)
8.3 Chronic Pulmonary Aspergillosis (CPA)
8.3.1 Overview
8.3.2 Global Chronic pulmonary aspergillosis (CPA) Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Allergic Bronchopulmonary Aspergillosis (ABPA)
8.4.1 Overview
8.4.2 Global Allergic bronchopulmonary aspergillosis (ABPA) Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Gastrointestinal Candidiasis
8.5.1 Overview
8.5.2 Global Gastrointestinal Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Genitourinary Tract Candidiasis
8.6.1 Overview
8.6.2 Global Genitourinary Tract Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Others
8.7.1 Overview
8.7.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

9. Systemic Aspergillosis and Systemic Candidiasis Market - Geographic Analysis
9.1 North America: Systemic Aspergillosis and Systemic Candidiasis Market
9.1.1 Overview
9.1.2 North America: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.1.4 North America: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.1.5 North America: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
9.1.6 US: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.1.6.3 US: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.1.7 Canada: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.1.7.3 Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.1.8 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.1.8.3 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.2 Europe: Systemic Aspergillosis and Systemic Candidiasis Market
9.2.1 Overview
9.2.2 Europe: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.2.4 Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.2.5 Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
9.2.6 Germany: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Germany: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Germany: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.2.6.3 Germany: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.2.7 UK: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.1 UK: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.2 UK: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.2.7.3 UK: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.2.8 France: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.1 France: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.2 France: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.2.8.3 France: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.2.9 Italy: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.1 Italy: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.2 Italy: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.2.9.3 Italy: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.2.10 Spain: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Spain: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Spain: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.2.10.3 Spain: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.2.11 Rest of Europe: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.11.1 Rest of Europe: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.11.2 Rest of Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.2.11.3 Rest of Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.3 Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market
9.3.1 Overview
9.3.2 Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.3.4 Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.3.5 Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
9.3.6 China: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.1 China: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.2 China: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.3.6.3 China: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.3.7 Japan: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.1 Japan: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.2 Japan: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.3.7.3 Japan: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.3.8 India: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.1 India: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.2 India: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.3.8.3 India: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.3.9 Australia: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.9.1 Australia: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.9.2 Australia: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.3.9.3 Australia: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.3.10 South Korea: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.10.1 South Korea: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.10.2 South Korea: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.3.10.3 South Korea: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.3.11 Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.11.1 Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.11.2 Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.3.11.3 Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.4 Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market
9.4.1 Overview
9.4.2 Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.3 Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.4.4 Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.4.5 Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
9.4.6 South Africa: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.1 South Africa: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.2 South Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.4.6.3 South Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.4.7 Saudi Arabia: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.1 Saudi Arabia: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.2 Saudi Arabia: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.4.7.3 Saudi Arabia: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.4.8 UAE: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.8.1 UAE: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.8.2 UAE: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.4.8.3 UAE: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.4.9 Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.9.1 Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.9.2 Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.4.9.3 Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.5 South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market
9.5.1 Overview
9.5.2 South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.5.3 South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.5.4 South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.5.5 South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
9.5.6 Brazil: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.5.6.3 Brazil: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.5.7 Argentina: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.5.7.3 Argentina: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.5.8 Rest of South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.5.8.1 Rest of South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.5.8.2 Rest of South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.5.8.3 Rest of South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)

10. Impact of COVID-19 Pandemic on Global Systemic Aspergillosis and Systemic Candidiasis Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment Of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Systemic Aspergillosis and Systemic Candidiasis Market-Industry Landscape
11.1 Overview
11.2 Recent Growth Strategies In The Systemic Aspergillosis And Systemic Candidiasis Market

12. Company Profiles
12.1 Novartis AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sanofi
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Pfizer Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Merck & Co., Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Bayer AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Astellas Pharma Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 GlaxoSmithKline plc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Abbott
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Cipla Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 ENZON PHARMACEUTICALS, INC
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

List of Tables
Table 1. Clinical Trials Phases of Products Offered by Companies
Table 2. Candida Specific Products
Table 3. Clinical cases of Candida auris reported by U.S. states, as of November 30, 2020
Table 4. North America Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 5. North America Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 6. US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 7. US: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027
Table 8. Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 9. Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 12. Europe Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 13. Europe Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 14. US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 15. Germany: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027
Table 16. UK: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 17. UK: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 18. France: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 19. France: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 20. Italy: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 21. Italy: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 22. Spain: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 23. Spain: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 24. Rest of Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 25. Rest of Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 26. Asia PacificSystemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 27. Asia PacificSystemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 28. US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 29. China: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027
Table 30. Japan: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 31. Japan: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 32. India: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 33. India: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 34. Australia: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 35. Australia: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 36. South Korea: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 37. South Korea: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 38. Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 39. Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 40. Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 41. Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 42. US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 43. South Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027
Table 44. Saudi Arabia: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 45. Saudi Arabia: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 46. UAE: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 47. UAE: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 48. Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 49. Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 50. South and Central America Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 51. South and Central America Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 52. US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 53. Brazil: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027
Table 54. Argentina: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 55. Argentina: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 56. Rest of South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 57. Rest of South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 58. Glossary of Terms, Systemic Aspergillosis And Systemic Candidiasis Market

List of Figures
Figure 1. Systemic Aspergillosis And Systemic Candidasis Market Segmentation
Figure 2. Systemic Aspergillosis And Systemic Candidasis Market, By Region
Figure 3. Global Systemic Aspergillosis And Systemic Candidasis Market Overview
Figure 4. Systemic Oral Azoles Segment Held Largest Share of Type Segment In Systemic Aspergillosis And Systemic Candidasis Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Systemic Aspergillosis And Systemic Candidasis Market, By Geography (USD Million)
Figure 7. Global Systemic Aspergillosis And Systemic Candidasis Market- Leading Country Markets (USD Million)
Figure 8. Global Systemic Aspergillosis And Systemic Candidasis Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Systemic Aspergillosis and Systemic Candidasis Market Impact Analysis of Drivers and Restraint
Figure 15. Global Systemic aspergillosis and systemic candidasis Market - Revenue Forecast And Analysis - 2019- 2027
Figure 16. Global Systemic Aspergillosis And Systemic Candidasis Market - By Geography Forecast and Analysis - 2019- 2027
Figure 17. Global Systemic Aspergillosis And Systemic Candidasis Market - By Geography Forecast and Analysis - 2019 - 2027
Figure 18. Global Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)
Figure 19. Global Voriconazole Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 20. Global Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Global Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Global Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Global others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Global Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)
Figure 25. Global Chronic pulmonary aspergillosis (CPA) Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 26. Global Allergic bronchopulmonary aspergillosis (ABPA)Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Global Gastrointestinal Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Global Genitourinary Tract Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Global others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. North America: Systemic Aspergillosis and Systemic Candidiasis Market, by Key Country - Revenue (2019) (USD Million)
Figure 31. North America: Systemic Aspergillosis and Systemic Candidiasis Market Revenue and Forecast to 2027 (USD Million)
Figure 32. North America: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
Figure 33. US: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 34. Canada: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 35. Mexico: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Key Country - Revenue (2019) (USD Million)
Figure 37. Europe: Systemic Aspergillosis and Systemic Candidiasis Market Revenue and Forecast to 2027 (USD Million)
Figure 38. Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
Figure 39. Germany: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 40. UK: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 41. France: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 42. Italy: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 43. Spain: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 44. Rest of Europe: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 45. Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Key Country - Revenue (2019) (USD Million)
Figure 46. Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market Revenue and Forecast to 2027 (USD Million)
Figure 47. Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
Figure 48. China: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 49. Japan: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 50. India: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 51. Australia: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 52. South Korea: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 53. Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 54. Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Key Country - Revenue (2019) (USD Million)
Figure 55. Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market Revenue and Forecast to 2027 (USD Million)
Figure 56. Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
Figure 57. South Africa: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 58. Saudi Arabia: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 59. UAE: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 60. Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 61. South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Key Country - Revenue (2019) (USD Million)
Figure 62. South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market Revenue and Forecast to 2027 (USD Million)
Figure 63. South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
Figure 64. Brazil: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 65. Argentina: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 66. Rest of South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 67. Impact of COVID-19 Pandemic in North American Country Markets
Figure 68. Impact of COVID-19 Pandemic on Systemic Aspergillosis And Systemic Candidiasis Market in Asia Pacific Countries
Figure 69. Impact Of COVID-19 Pandemic in Middle East and Africa Market
Figure 70. Impact Of COVID-19 Pandemic in South and Central America Market
Note: Product cover images may vary from those shown
  • Novartis Ag
  • Sanofi-Aventis
  • Pfizer, Inc
  • Merck And Co. Inc
  • Enzon Pharmaceuticals, Inc
  • Bayer Ag
  • Astellas Pharma Inc
  • Glaxosmithkline Plc
  • Abbott
  • Cipla
Note: Product cover images may vary from those shown
Adroll
adroll